Many pro-inflammatory markers increase during COVID-19, including IL-6 and MCP-1, which are key factors for the cytokine storm and acute inflammation caused by COVID-19 and contribute to chronic inflammation caused by NAFLD/NASH. This evidence concerns the gene IL6 and COVID-19.